3M - Coronavirus (COVID-19) Response

3M announced plans to provide $20 million in financial support to frontline healthcare workers, vulnerable populations disproportionately affected by the virus and medical research initiatives. 3M’s investment will be directed to community partners working to address critical needs during this global crisis. $10 million of the investment will provide community health centers with direct financial aid to support healthcare workers, $5 million will go toward United Way’s COVID-19 Community Response and Recovery Fund, and $5 million for COVID-19 research and development initiatives at leading education institutions in the United States and around the world (includes $2 million for the University of Minnesota).

3M is at maximum production of N95 respirators, doubling its global output to a rate of 1.1 billion per year, or 100 million per month. This includes 35 million per month in the United States, and over just a seven day period 3M delivered 10 million N95 respirators to healthcare facilities in states across the country.

The company put into motion additional investments and actions that will enable it to double capacity once again, to 2 billion globally within the next 12 months. In the United States, 3M expects to be producing N95 respirators at a rate of 50 million per month in June, a 40 percent increase from current levels. In the U.S., more than 90 percent of 3M's N95 respirators are going to healthcare and public health, with the remaining deployed to other critical industries such as energy, food and pharmaceuticals.

3M is partnering with Ford to bolster production of 3M’s powered air purifying respirators (PAPRs). 3M is moving forward quickly with the goal of increasing PAPR production by six-fold within the next 60 to 90 days.

3Mgives, the social investment arm of 3M, also pre-stocks supplies with humanitarian aid partners, and these product donations were provided to be rapidly deployed to affected communities. This is in addition to local 3M China product donations of respirators, surgical masks and hand sanitizer, totaling more than $1 million USD.

3M also continues its commitment to acting on reports of counterfeiting and price gouging related to 3M’s respirators.